Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
EBOS Group
EBOS Group
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
EBOS Group
Revenue
$13.2 B
FY, 2024
EBOS Group Summary
Company Summary
Overview
EBOS Group is a wholesaler and distributor of healthcare, medical, and pharmaceutical products. It offers diagnostic instruments, surgical instruments and prostheses, feminine protection, anesthetic equipment, and others.
Type
Public
Status
Active
Founded
1922
HQ
Docklands, AU
|
view all locations
Website
https://ebosgroup.com
Cybersecurity rating
ESG rating
50-59 out of 100
|
View all ESG data
Sectors
Healthcare
distribution
medical devices
medical diagnostics
Homepage
Linkedin
Table of Contents
Key People
Locations
Financials
Competitors
Key People
John Cullity,
Chief Executive Officer
Brett Barons,
Chief Executive Officer, Symbion
Andrea Bell,
Chief Information Officer
Janelle Cain,
General Counsel
Locations
View all
2 locations detected
Docklands, VIC
HQ
Australia
level 7/737 Bourke St
Christchurch, Canterbury
New Zealand
108 Wrights Road, Addington
Report incorrect company information
EBOS Group Financials
Summary Financials
Revenue (H1, 2025)
$6.0B
Gross profit (H1, 2025)
$799.3M
Net income (H1, 2025)
$111.7M
Cash (FY, 2024)
$216.9M
EBIT (H1, 2025)
$207.4M
Competitors and Similar Companies
Imagem Sistemas Médicos
Healthcare - Private
Sistemas Analiticos
Healthcare - Private
Thalys Medical Technology
Healthcare - Public
Immunoshop
Healthcare - Private
Compare competitors
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2025
Share price data provided by IEX
Back
to top